Scalable manufacturing and toxicity testing of intranasal M2SR influenza vaccine

Ended Project Grant Awarded Last action

Award ID
HT94252310246
Recipient
Awarding agency
Obligated
$5,599,997

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Madison, WI 53711, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

Flugen Inc. was awarded a $5.6 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of April 1, 2023 through March 31, 2026. The grant will support Flugen's work to develop scalable manufacturing and toxicity testing methods for an intranasal M2SR influenza vaccine. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions, including investigations to benefit service members in battlefield conditions. This award will help Flugen advance the vaccine candidate toward clinical trials and potential deployment to protect against influenza strains.

Quick answers

Who received award HT94252310246?

HT94252310246 was awarded to Flugen Inc. by Defense Health Agency (Department of Defense) on April 1, 2023.

How much is award HT94252310246 worth?

$5,599,997 has been obligated on HT94252310246.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login